11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - female - > 5,000 mg/kg (OECD Test Guideline 425)
Inhalation: No data available
Dermal: No data available
Skin corrosion/irritation
Skin - Rabbit
Result: No skin irritation - 4 h (OECD Test Guideline 404)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: No eye irritation - 1 s (OECD Test Guideline 405)
Respiratory or skin sensitization
May cause allergy or asthma symptoms or breathing difficulties if inhaled. (ECHA)
Germ cell mutagenicity
Test Type: Micronucleus test
Test system: Human lymphocytes
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 487
Result: negative
Test Type: Ames test
Test system: Escherichia coli/Salmonella typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: Chromosome aberration test in vitro
Test system: Human lymphocytes
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 473
Result: negative
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Rat - male and female - Oral - 90 Days - No observed ad- verse effect level - 1,000 mg/kg
RTECS: FI4378000
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.